FDA Under Siege: Trump Layoffs Threaten US Drug Review System
2025-04-04
Reuters
The Trump administration's sweeping layoffs at the US Food and Drug Administration have sparked concerns about the agency's ability to effectively review new drugs. As key employees are let go, the FDA's drug review system is beginning to erode, potentially putting public health at risk. With the FDA playing a critical role in ensuring the safety and efficacy of medications, the impact of these layoffs could be far-reaching. Pharmaceutical regulation, drug safety, and public health are all areas that may be affected by these changes, highlighting the need for careful consideration and oversight.